Login to Your Account



Pharma: Other News To Note


Wednesday, May 9, 2012
• Clinigen Healthcare, of Burton-on-Trent, UK, the pharmaceutical products division of Clinigen Group, said its supplemental new drug application for Foscavir (foscarnet sodium) in HIV/AIDS-related cytomegalovirus infections and herpes was approved by the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription